The US Food and Drug Administration has given clearance to another blood test to help assess Alzheimer’s disease and other ...

TORONTO — An expert panel convened by the Alzheimer’s Association has released the first clinical guidelines to help clinicians choose the most appropriate blood-based biomarker (BBM) test to aid in ...

SAN DIEGO--(BUSINESS WIRE)--Cue Health (“Cue”) (Nasdaq: HLTH), a healthcare technology company, today announced the nationwide launch of a new suite of consumer-friendly, at-home diagnostic test kits.

Learn about pet bloodwork, the tests involved, and how to interpret results to ensure your furry friend's health. Read the ...

DiabetesNow combines testing for 16 genes associated with monogenic forms of diabetes—including MODY, neonatal, syndromic, and mitochondrial types—with polygenic risk scores (PRS) for type 1 and type ...

A less invasive test for Alzheimer’s is a big advance. But it’s not perfect and is not meant to screen healthy people.

Elaine Chen covers biotech, co-writes The Readout newsletter, and co-hosts STAT’s weekly biotech podcast, The Readout Loud. You can reach Elaine on Signal at elaineywchen.70. A major Alzheimer’s ...

Agilent Technologies Inc. (NYSE: A) today announced that its MMR IHC Panel pharmDx (Dako Omnis) has received class C companion diagnostic (CDx) certification under EU in vitro diagnostic regulation ...

Researchers have adapted a rapid diagnostic technology that is able to identify undetected cases of malaria, helping tackle ...

Paper-based diagnostic tests such as rapid COVID-19 assays have broadened access to diagnostic tests beyond the lab. But historically, they have been limited to a binary readout: either yes or no. At ...